Autor: |
Rajesh, Chavan, Vineet, Zope, Nilesh, Chavan, Javeed, Shaikh, Kiran, Patil, Ravindra, Yeole, Sachin, Bhagwat, Mahesh, Patel |
Rok vydání: |
2020 |
Předmět: |
|
Zdroj: |
Xenobiotica; the fate of foreign compounds in biological systems. 50(10) |
ISSN: |
1366-5928 |
Popis: |
WCK 771 (INN: levonadifloxacin) is a novel antibacterial agent belonging to benzoquinolizine subclass of fluoroquinolones which is under clinical development as a parenteral formulation and its prodrug WCK 2349 (INN: alalevonadifloxacin) as an oral option. Both the drugs have been approved recently in India based on phase III trial completed for ABSSSI. |
Databáze: |
OpenAIRE |
Externí odkaz: |
|